Vivus Inc (VVUS):企業の財務・戦略的SWOT分析

◆英語タイトル:Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15902
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivus Inc (VVUS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet medical needs for the treatment of obesity, sleep apnea, diabetes, and sexual health. The company’s marketed products include, Qsymia (phentermine and topiramate extended-release), indicated for the chronic weight management in adult patients; and Stendra/Spedra (avanafil), an oral phosphodiesterase type 5, for erectile dysfunction. Its pipeline products include Qsymia for obstructive sleep apnea, nonalcoholic steatohepatitis, diabetes, nonalcoholic fatty liver disease and hyperlipidemia; and Tacrolimus for pulmonary arterial hypertension. Vivus works in partnership with pharmaceutical companies to advance of its product portfolio. It operates through its subsidiaries in the UK, the Netherlands, Ireland and Bermuda. Vivus is headquartered in Campbell, California, the US.

Vivus Inc Key Recent Developments

Feb 26,2019 VIVUS announces fourth quarter 2018 financial results
Jan 14,2019 Data Supporting the Cardiovascular Safety of VIVUS Qsymia Published in The Journal of Clinical Endocrinology & Metabolism
Nov 01,2018 VIVUS reports third quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vivus Inc – Key Facts
Vivus Inc – Key Employees
Vivus Inc – Key Employee Biographies
Vivus Inc – Major Products and Services
Vivus Inc – History
Vivus Inc – Company Statement
Vivus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vivus Inc – Business Description
Product Category: License and Milestone Revenue
Performance
Product Category: Pancreaze – Royalty Revenue
Performance
Product Category: Pancreaze Net Product Revenue
Performance
Product Category: Qsymia
Performance
Product Category: Stendra/Spedra Royalty Revenue
Performance
Product Category: Supply Revenue
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Vivus Inc – SWOT Analysis
SWOT Analysis – Overview
Vivus Inc – Strengths
Vivus Inc – Weaknesses
Vivus Inc – Opportunities
Vivus Inc – Threats
Vivus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vivus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 26, 2019: VIVUS announces fourth quarter 2018 financial results
Jan 14, 2019: Data Supporting the Cardiovascular Safety of VIVUS Qsymia Published in The Journal of Clinical Endocrinology & Metabolism
Nov 01, 2018: VIVUS reports third quarter 2018 financial results
Oct 29, 2018: VIVUS adds two new members to the Board of Directors
Oct 10, 2018: VIVUS to Present at the BIO Investor Forum on October 17, 2018
Sep 21, 2018: VIVUS Supports the Cystic Fibrosis Community Through Sponsorship of and Participation in the Cystic Fibrosis Foundation’s CF Climb
Aug 07, 2018: VIVUS reports second quarter 2018 financial results
Aug 06, 2018: VIVUS names Kenneth Suh as president
May 08, 2018: VIVUS Reports First Quarter 2018 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vivus Inc, Key Facts
Vivus Inc, Key Employees
Vivus Inc, Key Employee Biographies
Vivus Inc, Major Products and Services
Vivus Inc, History
Vivus Inc, Subsidiaries
Vivus Inc, Key Competitors
Vivus Inc, Ratios based on current share price
Vivus Inc, Annual Ratios
Vivus Inc, Annual Ratios (Cont...1)
Vivus Inc, Annual Ratios (Cont...2)
Vivus Inc, Interim Ratios
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vivus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Vivus Inc, Performance Chart (2014 - 2018)
Vivus Inc, Ratio Charts
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vivus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Vivus Inc (VVUS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oberg Industries, Inc.:企業の戦略的SWOT分析
    Oberg Industries, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kronos Worldwide, Inc. (KRO):企業概要、財務及び戦略的SWOT分析
    Summary Kronos Worldwide, Inc. (Kronos) is a chemical manufacturing company. The company manufactures and markets titanium dioxide pigments (TiO2). Its products include anatase pigments, rutile pigments, KRONOS ecochem, photocatalysts, and titanium chemicals. Kronos serves industries such as coating …
  • Dynatronics Corporation (DYNT):企業財務及び戦略的SWOT分析
    Summary Dynatronics Corporation (Dynatronics) is a medical device company that provides physical medicine products. The company manufactures, markets, and distributes orthopedic soft goods and supplies, medical equipment for physical medicine, treatment tables and rehabilitation equipment. Dynatroni …
  • Atlas Energy Group LLC:企業の戦略・SWOT・財務情報
    Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report Summary Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aptech Ltd. (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd. (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Carpevigo AG:企業のM&A・提携動向(発電分野)
    Summary Carpevigo AG (Carpevigo) is an alternative energy company that offers planning, control, implementation, management and energy recovery of photovoltaic power plants. The company offers project planning and construction; operations and management; energy generation, and trade and financing se …
  • Alabama Municipal Electric Authority:企業のM&A・提携動向(エネルギー分野)
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit electric utility that generates, procures, and supplies power. The authority generates electricity from gas source. It has operating interests in gas fried facility. AMEA procures electricity from open market and South Carolina …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Adimab LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Adimab LLC (Adimab) is an antibody discovery technology provider that provides antibody discovery and optimization platform. The company discovers antibodies for a range of disease areas including oncology, immunomodulation, neuroscience and pain, inflammation, cardiovascular and metabolic d …
  • Techfirm Inc. (3625):企業概要、財務及び戦略的SWOT分析
    Summary Techfirm Inc. (Techfirm) is an information technology service provider. The company provides technologies and services for engineers. It offers products such as android app AT-scan, android app AT-switch, delivery passbook corresponding CRM system the best coupon, smart phones refuge (sp tra …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Security Devices International Inc.:企業の戦略・SWOT・財務分析
    SummarySecurity Devices International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • IFCI Limited:企業のM&A・提携・投資分析
    IFCI Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IFCI Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Duro Bag Manufacturing Company:企業の戦略・SWOT・財務分析
    SummaryDuro Bag Manufacturing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Kunsul Chemical Industrial Co., Ltd. (000860):企業財務及び戦略的SWOT分析
    Summary Kunsul Chemical Industrial Co., Ltd. (Kunsul) is a paints and coatings service provider that offers products and services to architectural, industrial, automotive, and heavy duty and marine sectors. The company offers architectural products, professional products, diy products, and color boo …
  • GK Software AG (GKS):企業概要、財務及び戦略的SWOT分析
    Summary GK Software AG (GK Software) is a store solution provider. The company provides software solutions for the retail trade. Its products include product finder, SAP store solutions, GK-in-the-cloud, technology and standards, and internationalization. GK Software’s GK/retail suite offers market …
  • Calgro M3 Holdings Ltd:企業の戦略・SWOT・財務情報
    Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alnylam Pharmaceuticals, Inc.:製品開発パイプライン動向2015
    Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Alnylam Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehens …
  • Aqua Bio Technology ASA (ABT):企業概要、財務及び戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company. The company develops, produces and markets new active ingredients to the personal care industry. Its products include Aquabeautine XL, Beauty Propelline, Dermaclarine and Smids. The company’s Aquabeautine XL is derived from the hatchi …
  • Lee’s Pharmaceutical Holdings Limited (950)(製薬・医療分野):企業M&A動向
    Summary Lee's Pharmaceutical Holdings Limited (Lee's Pharm) is a pharmaceutical company. It comprises of four GMP-compliant workshops. The company undertakes the production of lyophilized powder for injection, topical gel, small volume parenteral solutions and eye gel. The product portfolio of the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆